Help want­ed: CEO need­ed to run a new $330M fund in search of break­through biotech ideas

Right now, sea­soned biotech teams with good con­nec­tions and a sol­id de­vel­op­ment plan for risky but com­mer­cial­ly promis­ing drugs are op­er­at­ing in a world with rapid­ly ris­ing lev­els of cash chas­ing a lim­it­ed num­ber of top prospects. But the Well­come Trust still sees a crit­i­cal lack of seed fund­ing for bright, pre­clin­i­cal ideas on the side­lines.

And they aim to fill part of it with a new $330 mil­lion fund that can be se­lec­tive­ly bril­liant.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER